Skip to content

Dr. Reddy's Laboratories

US · RDY #1451 by market cap Listed 1970
14.89 +0.06 +0.40%
Periodic snapshot; not a real-time feed. · 2026-11-20 20:02

Quant vs Street three independent views, side by side

StockVane factor grade
C
Momentum strategy signal
Hold
Analyst consensus
Buy

Mostly aligned, one view stands apart.

Not investment advice. The factor grade ranks this stock on fundamentals against StockVane's covered universe; the momentum strategy signal is a rules-based backtest, not a recommendation; analyst consensus reflects sell-side coverage. The three use different methods and can reasonably disagree.

Analyst consensus 3 analysts

Buy
Avg price target 14.40 -3.3%
Price target rangecurrent 14.89
Low14.00
Avg14.40
High14.80
Buy 67% Hold 33% Sell 0%
Recent ratings (5)
DateFirmAnalystRatingTarget
2026-10-26 BofA Securities -- Buy --
2026-10-25 Jefferies -- Hold 14.00
2026-10-12 BNP Paribas -- Buy 14.80
2026-10-01 BofA Securities -- Buy --
2026-06-18 BofA Securities -- Buy 16.04

Earnings history price reaction on the day

PeriodReport dateSessionOptions expectedActual move
2027/Q2 2026-10-23 -- ±8.70% -0.15% (in line)
2027/Q1 2026-07-22 -- ±7.98% -9.39% (beat)
2026/Q4 2026-05-12 -- -- -5.18%
2026/Q3 2026-01-21 -- ±10.64% +2.63% (in line)
2026/Q2 2025-10-24 -- ±11.63% -0.27% (in line)
2026/Q1 2025-07-23 -- -- +1.32%
2025/Q4 2025-05-09 -- ±15.02% +1.67% (in line)
2025/Q3 2025-01-23 -- ±12.59% -6.23% (in line)
2025/Q2 2024-11-05 -- ±4.60% -1.27% (in line)
2025/Q1 2024-07-29 -- ±7.39% +0.99% (in line)
2024/Q4 2024-05-07 -- ±5.84% -4.73% (in line)
2024/Q3 2024-01-30 -- ±7.72% -0.93% (in line)

"Options expected" is the pre-earnings options market's implied move (a straddle-style estimate), shown next to what actually happened.

Quote time 2026-11-20 20:02:31 · For reference only, not investment advice and not tailored to your situation.

Dr. Reddy's Laboratories discussion 0 comments

Add a comment